GCCL provides various services in developing and verifying analysis methods and analyzing biomarkers based on state-of-the-art equipment and specialists for PK/PD analysis in preclinical and early clinical trial phases.
> Bio-Analytical Laboratory > Bio-analysis
With the increase in new drug pipelines and clinical trials worldwide, the demand for preclinical analysis and clinical development
consulting as well as analysis services in early clinical trials is also increasing, which raises the need for extensive
analytical competencies and improved quality of analysis.
Based on state-of-the-art equipment and specialists, GCCL provides various
services in developing and verifying analysis methods and analyzing biomarkers for PK/PD analysis
in preclinical and clinical trials.
GCCL quantifies analytes present in biological samples, such as plasma, whole blood, serum, and urine, generated from clinical pharmacology tests, bioavailability tests, and bioequivalence studies to apply for the approval of new and generic drugs.
By offering one-stop solutions for clinical trials, GCCL provides integrated services, such as blood concentration analysis for early clinical trials, as well as optimized services for the characteristics of the developed drugs by connecting with major clinical trial centers.
GCCL is capable of accurately detecting even the slightest amount of a substance and verifies equivalences with reference substances based on the latest LC-MS/MS equipment and researchers with extensive experience in bioequivalence studies.
GCCL shares its abilities with its partners through broad experience in the development and verification of various methods for PK/PD analysis as well as biomarker analysis services.